Key result
Ascorbic acid cuts AKI ~57% vs placebo during cardiac surgery with cardiopulmonary bypass.
Why the study?
Many methods used to prevent acute postoperative renal complications in cardiac surgery have shown various results, prompting a comparison between ascorbic acid and isotonic sodium bicarbonate.
Does ascorbic acid reduce acute kidney injury and acute renal failure in adult patients undergoing elective cardiac surgery using cardiopulmonary bypass compared to sodium bicarbonate or placebo?
RCT (n=150)
Double-blind
Randomized
No
Does ascorbic acid reduce acute kidney injury and acute renal failure in adult patients undergoing elective cardiac surgery using cardiopulmonary bypass compared to sodium bicarbonate or placebo?
Absolute Event Rate: 12% vs 28%
p-value: p=0.043
Intraoperative infusion of ascorbic acid is more effective than sodium bicarbonate or placebo in preventing acute kidney injury and acute renal failure after cardiac surgery with cardiopulmonary bypass.
Supports ascorbic acid for AKI prevention in CPB surgery; confirms benefit over sodium bicarbonate in this RCT.
Background: Many methods have been used to prevent acute postoperative renal complication in cardiac surgery, with various results. The purpose of the present study was to compare ascorbic acid versous isotonic sodium bicarbonate in the prevention of acute postoperative renal complication in adult cardiac surgery using cardiopulmonary bypass (CPB). Methods: In a clinical trial, 150 adult patients scheduled for elective cardiac surgery using CPB, enrolled to this study in three ascorbic acid, sodium bicarbonate and placebo groups (each group=50). During surgery, 1000 ml of normal saline was infused in a 2 hours period that contain ascorbic acid 500mg, sodium bicarbonate 8.4% 75 ml or saline alone, respectively. Invasive hemodynamic and urinary output monitoring was done intra and post-operatively. An increase more than 0.5mg/dl or more than 25% in basic plasma creatinine (Cr) or decrease more than 25% in basic glomerular filtration rate (GFR), was considered as acute kidney injury (AKI). An increase or decrease of more than 50% in basic Cr or GFR, respectively, was considered as acute renal failure (ARF). Data were analyzed using X2, student t-test and ANOVA tests. Results: AKI and ARF were occurred in 36 and 9 patients, respectively (P=0.043 and P=0.001, respectively), those were lesser in ascorbic acid group The renal protective effect of the ascorbic acid occurred for longer period than bicarbonate. Conclusion: Comparing to sodium bicarbonate and placebo groups, ascorbic acid is more effective in prevention of the acute postoperative renal complication in adult cardiac surgery using CPB.
No takes yet. Share an insight, caveat, or question.
Bilehjani et al. (2019) conducted an RCT in Acute postoperative renal complication after cardiac surgery (n=150). Ascorbic acid vs. Sodium bicarbonate or placebo was evaluated on Acute kidney injury (AKI) (p=0.043). Ascorbic acid significantly reduced the incidence of acute kidney injury to 12% compared to 32% with sodium bicarbonate and 28% with placebo in adult patients undergoing cardiac surgery with cardiopulmonary bypass.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: